These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 31106604)
1. A case of significant hypotension following a human ingestion of veterinary pimobendan. Brett J; Wylie C; Brown J Clin Toxicol (Phila); 2020 Feb; 58(2):146-148. PubMed ID: 31106604 [No Abstract] [Full Text] [Related]
2. Clinical signs of cardiovascular effects secondary to suspected pimobendan toxicosis in five dogs. Reinker LN; Lee JA; Hovda LR; Rishniw M J Am Anim Hosp Assoc; 2012; 48(4):250-5. PubMed ID: 22611208 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750 [TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy. Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765 [TBL] [Abstract][Full Text] [Related]
6. Systemic Toxicity Following the Use of 1% Ropivacaine for Pediatric Penile Nerve Block. Najafi N; Veyckemans F; Du Maine C; van de Velde A; de Backer A; Vanderlinden K; Poelaert J Reg Anesth Pain Med; 2016; 41(4):549-50. PubMed ID: 27315186 [No Abstract] [Full Text] [Related]
7. Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency. Przechera M; Roth W; Kühlkamp V; Risler T; Haehl M Eur J Clin Pharmacol; 1991; 40(1):107-11. PubMed ID: 2060537 [TBL] [Abstract][Full Text] [Related]
8. Effect of pimobendan on cardiopulmonary baroreflex control of sympathetic nerve activity in healthy young men. Maruyama M; Takamura M; Takata S; Murai H; Usui S; Furusho H; Sakagami S; Yuasa T; Shimakura A; Kaneko S Auton Neurosci; 2005 Oct; 122(1-2):100-6. PubMed ID: 16199209 [TBL] [Abstract][Full Text] [Related]
9. Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction. Lynch JJ; Uprichard AC; Frye JW; Driscoll EM; Kitzen JM; Lucchesi BR J Cardiovasc Pharmacol; 1989 Oct; 14(4):585-97. PubMed ID: 2478772 [TBL] [Abstract][Full Text] [Related]
10. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations. Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887 [TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamics of pimobendan in chronic heart failure. A comparative crossover study of captopril and pimobendan. Tsuda T; Izumi T; Kodama M; Hanawa H; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Kuwano H; Shibata A Jpn Heart J; 1992 Mar; 33(2):193-203. PubMed ID: 1593749 [TBL] [Abstract][Full Text] [Related]
12. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy. Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096 [TBL] [Abstract][Full Text] [Related]
13. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure. Ishiki R; Ishihara T; Izawa H; Nagata K; Hirai M; Yokota M J Cardiovasc Pharmacol; 2000 Jun; 35(6):897-905. PubMed ID: 10836724 [TBL] [Abstract][Full Text] [Related]
14. Management of acute myocardial infarction with hypotension. Noble RJ; Tavel ME Chest; 1999 Nov; 116(5):1464-7. PubMed ID: 10559114 [No Abstract] [Full Text] [Related]
15. A Case of Severe, Refractory Hypotension After Amlodipine Overdose. Chudow M; Ferguson K Cardiovasc Toxicol; 2018 Apr; 18(2):192-197. PubMed ID: 28688059 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489 [TBL] [Abstract][Full Text] [Related]
17. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. O'Grady MR; Minors SL; O'Sullivan ML; Horne R J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880 [TBL] [Abstract][Full Text] [Related]
18. Aconite poisoning presenting as hypotension and bradycardia. Chan TY Hum Exp Toxicol; 2009 Dec; 28(12):795-7. PubMed ID: 19880659 [TBL] [Abstract][Full Text] [Related]
19. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril. Hauf GF; Grom E; Jähnchen E; Roskamm H J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793 [TBL] [Abstract][Full Text] [Related]
20. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent. Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]